Former Secretaries of the Treasury Robert E. Rubin and Henry M. Paulson, Jr. will share their thoughts on the state of the global economy during a Keynote Luncheon panel at the 2012 BIO International Convention. BIO President and CEO Jim Greenwood will moderate the discussion and deliver state of the industry remarks.
Read the press release
Learn more about the 2012 International Convention
BioCentury This Week TV offers a double feature: The University of Kentucky's Dr. Glen Mays explains the IOM's call for a life expectancy goal in the U.S. And in a "Point of View" interview, Nobel winner Dr. Barry Marshall describes what it takes to overcome scientific dogma.
“Farm Bill energy programs are working and BIO member companies are beginning to put steel in the ground,” BIO President & CEO Jim Greenwood said in testimony to the House Agriculture Subcommittee on Conservation, Energy, and Forestry.
The FDA recently held a hearing on biosimilars, which are under their consideration to come to the United States. Sara Radcliffe, BIO Executive Vice President for Health, and Richard M. Dolinar, M.D., Chairman of the Alliance for Safe Biologic Medicines, testified at the hearing.
Download Radcliffe's Presentation
Read a blog post on BIOtechNOW from Dolinar
A new survey released by the International Food Information Council (IFIC) shows that U.S. consumers overwhelmingly support current federal rules for labeling foods. Only 1 percent of the total sample cited biotechnology as an information need on the label.
At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet. We have used the biological processes of microorganisms for more than 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.
|
Biotechnology’s Impact on Food Ingredients
Natural biological processes have been...
|
Laws and proposals can go a long way toward fostering biomedical innovation in the U.S. The...
|
BIO has long supported responsible and ethical testing, protection of individual privacy and...
|
